Back to resources

Resources

Displaying 1 - 8 of 188

The UK Life Sciences Permanent Market Just Turned For The First Time in Four Years
Permanent placements in the UK rose last month. That hasn't happened since September 202...

By Barrington James October 1st, 2026
Ex vivo vs in vivo CAR-T and gene therapy.
Autologous cell therapy works, 17 approved by the FDA so far, the constraint has always been...

By Holly Wallner September 28th, 2026
https://sitescdn.wearevennture.co.uk/public/barrington-james/assets/cgt-hiring-trends-2026-whitepaper-aaf00f42c14f4f08b629376a59f84862.webp

Navigating Cell & Gene Therapy Hiring Trends And The 2026 Outlook.
The cell and gene therapy market is shifting from scientific potential towards operational d...

By Brandon Schelkle September 23rd, 2026
Medical Device
The FDA’s Next Decade Will Reshape Device Regulatory Hiring
CDRH Signals a Decade-Long Regulatory Science AgendaOn 25 September, the FDA's Center for De...

By Barrington James September 21st, 2026
From Funding to Regulation: The Talent Challenges Reshaping Digital Health.
Digital Health Funding Rebounded into Fewer HandsThe funding winter is over, though the thaw...

By Barrington James & Kyle Nelson September 14th, 2026
Life Sciences Hiring Trends 2026: Five Market Signals Shaping Q4
As the life sciences industry moves into the final quarter of 2026, the hiring picture is be...

By Barrington James September 9th, 2026
The UK Trial Boom: How Faster MHRA Approvals Are Reshaping Clinical Trial Site Operations
The MHRA's 2026 reforms have cut clinical trial approvals from 169 to 122 days. Here'...

By Luke Chase August 21st, 2026
The Neuro/CNS Talent Market in 2026: What Top Candidates Really Want
Understanding the competitive landscape and what it takes to attract and retain elite commer...

By Barrington James August 20th, 2026